Sanofi to Put Christel Heydemann’s Independent Director Appointment to Shareholder Vote April 29, 2026

Reuters16:16
<a href="https://laohu8.com/S/GCVRZ">Sanofi</a> to Put Christel Heydemann’s Independent Director Appointment to Shareholder Vote April 29, 2026

Sanofi SA shareholders will vote at the company’s Annual General Meeting on April 29, 2026 on a board proposal to appoint Christel Heydemann as an independent director, alongside proposals to renew the mandates of directors Christophe Babule and Jean-Paul Kress. Shareholders are recommended to vote yes on the proposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603050316OMX_____CNEWS_EN_GNW1001168369_en) on March 05, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment